Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study

Toxicology

Volumn 185, Issue 1-2, 2003, Pages 17-22

  Okamura, Miwa ^a   Kashida, Yoko ^a   Watanabe, Takao ^a   Yasuhara, Kazuo ^b   Onodera, Hiroshi ^b   Hirose, Masao ^b   Usui, Toshimi ^c   Tamaoki, Norikazu ^c   Mitsumori, Kunitoshi ^a,b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Carcinogenicity; Knockout mice; P53; Phenolphthalein

Indexed keywords

PHENOLPHTHALEIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; KNOCKOUT MOUSE; LYMPHOMA; MALE; METASTASIS; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TEST MEAL;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; MALE; MICE; MICE, INBRED CBA; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; PHENOLPHTHALEIN;

EID: 0037436394     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00586-3     Document Type: Article

References (17)

1. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr, Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
2. Donehower L.A., Harvey M., Vogel H., McArthur M.J., Montgomery C.A. Jr, Park S.H., Thompson T., Ford R.J., Bradley A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinogenesis. 14:1995;16-22.
3. Dunnick J.K., Hailey J.R. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res. 56:1996;4922-4926.
4. Dunnick J.K., Hardisty J.F., Herbert R.A., Seely J.C., Furedi-Machacek E.M., Foley J.F., Lacks G.D., Stasiewicz S., French J.E. Phenolphthalein induces thymic lymphomas accompanied by loss of p53 wild type allele in heterozygous p53-deficient (±) mice. Toxicol. Pathol. 25:1997;533-540.
5. Haseman J.K., Elwell M.R., Hailey J.R. Neoplasm incidence in B6C3F1 mice: NTP histrical data. Maronpot R.R. Pathology of Mouse. 1999;679-689 Cache River Press, Vienna, IL.
6. Koujitani T., Yasuhara K., Usui T., Nomura T., Onodera H., Takagi H., Hirose M., Mitsumori K. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study. Cancer Lett. 52:2000;211-216.
7. McMohan A.P., Bradley A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell. 62:1990;1073-1085.
8. National Institutes of Health, 1981. NIH Rodents, 1980 Catalogue. NIH Publication No. 81-606. Bethesda, Maryland, pp. 21-28.
9. National Toxicology Program (NTP), 1996. Toxicology and carcinogenesis studies of phenolphthalein in F344/N rats and B6C3F1 mice (feed studies). NTP Technical Report No. 456, US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda.
10. Park C.B., Kim D.J., Uehara N., Takasuka N., Hiroyasu B.T., Tsuda H. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline (MeIQx) carcinogenicity. Cancer Lett. 139:1999;177-182.
11. Popova N.V. Transgenerational effect of orthoaminoasotoluol in mice. Cancer Lett. 46:1989;203-206.
12. Popova N.V. Perinatal selenium exposure decrease spontaneous liver tumorigenesis in CBA mice. Cancer Lett. 179:2002;39-42.
13. Reo G.N., Collins B.J., Giles H.D., Health J.E., Foley J.F., May R.D., Buckley L.A. Carcinogenicity of 2′,3′-dideoxycytidine in mice. Cancer Res. 56:1996;4666-4672.
14. Stutman O. Cell-mediated immunity and aging. Fed. Proc. 33:1974;2028-2032.
15. Tillmann T., Kamino K., Mohr U. Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice. Exp. Toxicol. Pathol. 52:2000;221-225.
16. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
17. Yagi T., Tokunaga T., Furuta Y., Nada S., Yoshida M., Tsukada T., Saga Y., Takeda N., Ikawa Y., Aizawa S. A novel ES-cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214:1993;70-76.